A blood test still in its early stages is poised to detect a range of diseases, including cancer, diabetes and multiple sclerosis. It is based on next-generation DNA sequencing, using signatures of DNA coming from dying cells.
A blood test still in its early stages is poised to detect a range of diseases, including cancer, diabetes and multiple sclerosis. It is based on next-generation DNA sequencing, using signatures of DNA coming from dying cells.
Share this Article
Recommended